Last edition
News about "ILUMYA (Tildrakizumab)"
Sun Pharma Introduces ILUMYA in India for Plaque Psoriasis Treatment
Sun Pharma has launched its global innovative drug, ILUMYA (Tildrakizumab), in India for the treatment of moderate-to-severe plaque psoriasis.
ILUMYA (Tildrakizumab) | 01/12/2025 | By Dineshwori | 179
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members